Editor of Patient Care Online.
Daily Dose: Most Long COVID Outcomes Resolve in 1 Year After Mild Infection
Your daily dose of clinical news you may have missed.
Comparison of Loop Diuretics Shows No Difference in Heart Failure Survival
After hospital discharge for heart failure, adults treated with either furosemide or torsemide had similar mortality rates, according to results from the TRANSFORM-HF clinical trial.
Daily Dose: Women More Seriously Affected by Cluster Headaches
Exacerbation History as Sole COPD Risk Predictor May be Flawed, Associated with Risk of Harm
Exacerbation history alone is unlikely to provide clinical utility for predicting future COPD exacerbations and could be associated with a risk of harm, according to new analysis.
FDA Approves Label Update for Semaglutide as a First-line Type 2 Diabetes Medication
The update removes a previous limitation that stated semaglutide should not be used as an initial therapy for treating patients with T2D.
Women May be More Seriously Affected by Cluster Headaches, Suggests New Research
In a study of 874 adults, more women were diagnosed with chronic cluster headache and experienced longer attacks compared with men.
Daily Dose: School-based Gardening Program Improved Metabolic Parameters in At-risk Youth
Top 10 Diets for 2023: US News & World Report Rankings
US News and World Report released its annual “Best Diets” rankings for 2023. Out of nearly 40 of the most popular diets ranked by health experts, these 10 came out on top.
School-based Gardening Program Improved Glucose Control, Reduced LDL-C in At-risk Children
Findings suggest that school-based gardening, nutrition, and cooking interventions may improve metabolic parameters in high-risk children.
15 Drugs Approved for Primary Care in 2022
Get a quick look at 15 of the many FDA-approved drugs in 2022 for conditions commonly seen in primary care.
Youth who Feel Loved, Optimistic, and Happy More Likely to Maintain Good Cardiometabolic Health into Adulthood
Adolescents with more positive psychological assets were more likely to have good cardiometabolic health 2 decades later, and associations were stronger for Black youth.
Obesity Phenotypes: A Primary Viewpoints Podcast
"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Mayo Clinic's Andres Acosta, MD, PhD.
Daily Dose: Autoimmune Disorders Associated with New-onset Atrial Fibrillation
Daily Dose: Universal DAA Therapy for all Persons with HCV
Autoimmune Disorders Associated with New-onset AF and More Distinct in Women, Shows New Study
Findings elaborate on the pathophysiological differences in autoimmunity and atrial fibrillation risk between men and women.
Daily Dose: Obesity in Preschool-aged Children during COVID-19
New Findings Underscore Need for Universal DAA Therapy for all Persons with Hepatitis C Virus Infection
Direct-acting antiviral treatment was independently associated with a lower risk of mortality and liver and nonliver outcomes in a large study of adults with chronic hepatitis C.
Obesity in Preschool-aged Children in Sweden Increased during COVID-19, New Study Finds
Findings highlight the need for extended efforts directed to prevent childhood obesity, especially targeting lower socioeconomic areas, say study authors.
Daily Dose: Acupuncture for Irritable Bowel Syndrome
Mediterranean Diet Associated with Lower Risk of Adverse Pregnancy Outcomes, Suggests New Study
Findings showed that greater concordance to the Mediterranean diet was linked to a 21% lower risk of developing any adverse pregnancy outcomes.
Speculation Continues on Cause of Damar Hamlin’s On-field Cardiac Arrest
Commotio cordis is among the theories circulating around Buffalo Bills safety Damar Hamlin's on-field cardiac arrest.
Waning Protection from Pfizer-BioNTech COVID-19 Vaccine at 3 Months in Children is Restored, Sustained for 3 Months by Monovalent Booster
A new study points to the Pfizer shot's initially limited protection against the COVID-19 Omicron variant in those aged 5-11 years and also the the value of vaccine boosters.
FDA Approves Novel Capsid Inhibitor for Super-Refractory HIV-1 Infection
Lenacapavir is the first of a new class of antiretrovirals, and it is indicated for persons with multidrug resistance, intolerance, or safety considerations.
Daily Dose: Variable BMI Pattern May Serve as Indicator for Dementia
Daily Dose: Bivalent Boosters Protect Against Severe COVID-19 Disease
Topline Data Suggests Novel Pain Therapy Cebranopadol Has Significantly Less Potential for Abuse Compared to Tramadol, Oxycodone
Data from a phase 1 study of nondependent recreational opioid users suggests cebranopadol has a lower potential for abuse compared to C-II and C-IV opioids
Daily Dose: Concomitant Gestational Diabetes, Hypertensive Disorder Raise Long-term Postpartum CVD Risk
5 New Drugs Approved for Primary Care: Q4 2022
The end of another quarter means a new list of FDA-approved drugs for conditions treated in primary care. Are you up-to-date? Click through to find out.
Daily Dose: Statin Treatment, Duration Linked to Reduced Risk of Hemorrhagic Stroke
Daily Dose: Pediatric Obesity Treatment
